NEW ARTICLE: Animalcare has the answers "Animalcareâs annual report is a model for other smaller companies. Not only does it have answers, but the answers are reassuring.Reading through the report, I couldnât help but compare it to ECO Animal Healthâs. The two companies are in similar ..."[link]
QPP RNS Complete denial of any plans to sell its stake in NAR.[link] due diligence
Guyane From Wessex's Results announcement, today:-"In Guyane, the partners have largely completed the evaluation and interpretation of the valuable body of information derived from drilling and the new Central Area 3D seismic. A new portfolio of leads and prospects has now been defined in the, so far untested, Central Area. Discussion amongst partners on applying for a new drilling permit (AOT), a prerequisite to drilling a further well, is ongoing. However, given the long lead-time in determining an AOT and subsequently securing a deep-water rig, it is unlikely that any further drilling could occur before the end of 2015. Any further well would have to be drilled before the expiry of the exploration phase of the Guyane Maritime Permit in June 2016, unless it can be extended."
I wasn't fast enough this morning to buy some more is going up again
Re: Recent news and share price movement JamesBZ,Still 54% down even after yesterday's 111% rise and today's 35+%.There was a time when I was in profit - and will be again, I hope. Long term holder.
Break even!!!!! More than doubled revenues and broken even. Well done Plant Impact. It has been a long wait
Re: Updated Technicals What's going on???TEMPORARY SUSPENSION OF TRADING ON AIM AFRICAN MINERALS LIMITEDTrading on AIM for the under-mentioned securities has been temporarily suspended from 20/11/2014, 7:55am, pending an announcement. Common shares of USD0.01, fully paid (B00Z305) (BMG0114P1005)If you have any queries relating to the above, please contact the company's nominated adviser on 0207 029 8000.
Results/Meeting So Finals out on 2nd Dec....also there's a Shares Magazine event the next day where INFA are presenting, the 1st time I've known them do one of these presentations, link below:-[link] the stock is at c2 year lows, despite perhaps the most active period of catalysts ahead that they've had for a while...Maybe if there's confidence the directors could add to their stakes post the Finals...
VS LEG could well follow Fitbug in sp performance once VS either comes to market or there is a trade sale. LEG has the holding it in its books based on a £25m valuation but this could float at £100m plus, substantially increasing the LEG valuation. Bosques 40% could also be worth a substantial amount, but is only in the books at £100k. LEG is a rocket waiting to be lit IMO
Re: PRU Broker Updates.... From The Motley Fool today........Aviva plc, Legal & General Group Plc And Prudential plc Have Completely Thrashed This MarketHarvey Jones - Wednesday, 19 November, 2014 When I did a portfolio spring clean earlier this year there were two stocks I didnt even consider dumping: insurance giants Aviva (LSE: AV) and Prudential (LSE: PRU).Im glad I held onto them, because both have thrashed the wider stock market, as has the other big name in the life sector, Legal & General Group (LSE: LGEN).How To Crush The MarketWhile the FTSE 100 has stagnated over the last 12 months, Aviva is up 25%, L&G is up 16% and the Pru is up 18%.Thats tremendous performance in what should have been a difficult period, given market stagnation, and Chancellor George Osbornes radical pensions overhaul, which instantly halved annuity sales.Prus Aim Is TruePru has smashed analyst expectations again, with double-digit growth year-to-date in both new business profits and annual premiums across its three life businesses in the UK, US and Asia.Its asset management business also saw net inflows of £9.6bn, including strong performance in the UK.The Pru share price is up 150% over the last three years, and although its 2.23% dividend yield disappoints, there is plenty of scope for progression on that front.A Legal MatterL&G also has momentum on its side, its share price up 136% over three years. Q3 results showed impressive growth in revenues, operating profits, customers and net cash, and a continuing strong return on equity.Individual annuity sales fell 60%, but the bulk annuity market is more than compensating, while its investment management business saw total assets increase by £82bn to £676bn.Its 3.8% yield trumps both Prudential and the FTSE 100 average of 3.5%.Viva AvivaAviva is playing catch up with its runaway rivals, but I bought it as a recovery play, and it is steadily getting there. Its net asset value is up 10% year-to-date, new business is up 15% by value and its general insurance combined ratio has improved to 95.9%. Aviva may lack Prudentials exposure to fast-growing Asian markets, but its tighter focus on the UK and Europe has served it well. Although its 2.8% yield hardly thrills.Reassuringly ExpensiveAll three insurers benefit from low interest rates (which force savers to consider more dynamic alternatives), ageing Western and Asian populations, and the push to encourage private pension provision.Success comes at a price, however. All three look expensive right now, with L&G and the Pru trading at around 16 times earnings, and Aviva at 24 times.Given their breakneck growth, that may be a price worth paying.
RNS..Annual financials Very good report showing a healthy improvement in our situation.Regards, TP
Re: Encouraging Placing today at 105p so not good news for PI's as you say
RNS..Chairman's address Contains a useful summary of where we are.
Re: top up 2 [link] gone through the ISDX
Re: Won bid Look forward to his comments........
Latest from the Community...
Latest from the Community...
Latest from the Community...